Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam vs midazolam plus maternal presence for pain and anxiety during lumbar puncture in infants
IRCT201609222639N19Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of midazolam in central nervous system conditions (CNSD) (2 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoints: Pain reduction during lumbar puncture and Anxiety reduction during lumbar puncture. Started Mar 2015; status: completed.
02
Drugs
midazolam
03
Conditions
central nervous system conditions (CNSD)
Beyond the preview
Go deeper on IRCT201609222639N19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201609222639N19.